Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS)

Overview of attention for article published in Health and Quality of Life Outcomes, January 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Readers on

mendeley: 34 Mendeley

Summary X Facebook

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 15,362 followers.

RT @bvsspa: 📖 Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal... de…

06 Dec 2022

Reply Repost Favourite

📖 Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal... de @HRegionalMalaga @HUVV_SAS @_ibima @ibis_sevilla depositado en ⬇️⬇️⬇️ https://t.co/0MfbK38mxR #repositoriosalud #OA #ProduccionCi

06 Dec 2022

Reply Repost Favourite

#PubSaludMurcia Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS) @Area6VegaMedia https://t.co/u3HOHblu4n

08 May 2021

Reply Repost Favourite

Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS) https://t.co/CXQW1Oof6i #hvhebron #onco [Text complet] @BioMedC

02 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.